The roots of Prolytic GmbH can be traced back to ASTA Medica AG, a pharmaceutical research company and formerly wholly owned subsidiary of Degussa AG.
The new owner of Degussa, e.on AG, focused its business strategy mainly on energy and chemistry and thus decided to divest ASTA Medica splitting it up into different business units.
The biggest unit, Viatris GmbH & Co. KG, was sold to a finance investor whose new philosophy did not include the drug development sections “Bioanalysis” and “Pharmacokinetics.” Therefore, with the help of the management of Viatris GmbH & Co. KG, which provided the necessary equipment, an experienced group of scientists from these sections founded Prolytic GmbH in December 2002 with the aim of offering their abundant experience in bioanalysis and pharmacokinetics to clients in the pharmaceutical sector.
In September 2020 Prolytic became part of the Kymos group.
Please find more information about Kymos at: https://www.kymos.com/